CO5280223A1 - Nuevos compuestos - Google Patents

Nuevos compuestos

Info

Publication number
CO5280223A1
CO5280223A1 CO01025487A CO01025487A CO5280223A1 CO 5280223 A1 CO5280223 A1 CO 5280223A1 CO 01025487 A CO01025487 A CO 01025487A CO 01025487 A CO01025487 A CO 01025487A CO 5280223 A1 CO5280223 A1 CO 5280223A1
Authority
CO
Colombia
Prior art keywords
group
formula
compound
mfi
jpeg
Prior art date
Application number
CO01025487A
Other languages
English (en)
Spanish (es)
Inventor
Gerald Brooks
Eric Hunt
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0008260.2A external-priority patent/GB0008260D0/en
Priority claimed from GB0027182A external-priority patent/GB0027182D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of CO5280223A1 publication Critical patent/CO5280223A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
CO01025487A 2000-04-04 2001-03-30 Nuevos compuestos CO5280223A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0008260.2A GB0008260D0 (en) 2000-04-04 2000-04-04 Novel compounds
GB0027182A GB0027182D0 (en) 2000-11-04 2000-11-04 Novel comounds

Publications (1)

Publication Number Publication Date
CO5280223A1 true CO5280223A1 (es) 2003-05-30

Family

ID=26244040

Family Applications (1)

Application Number Title Priority Date Filing Date
CO01025487A CO5280223A1 (es) 2000-04-04 2001-03-30 Nuevos compuestos

Country Status (21)

Country Link
US (1) US6972297B2 (enExample)
EP (1) EP1268443B1 (enExample)
JP (1) JP2003529593A (enExample)
KR (1) KR100758441B1 (enExample)
CN (1) CN1210267C (enExample)
AR (1) AR030203A1 (enExample)
AT (1) ATE437860T1 (enExample)
AU (2) AU6382701A (enExample)
BR (1) BR0109809A (enExample)
CA (1) CA2405132A1 (enExample)
CO (1) CO5280223A1 (enExample)
CZ (1) CZ20023290A3 (enExample)
DE (1) DE60139382D1 (enExample)
ES (1) ES2328109T3 (enExample)
HU (1) HUP0300370A3 (enExample)
IL (1) IL151887A0 (enExample)
MX (1) MXPA02009816A (enExample)
NO (1) NO324229B1 (enExample)
NZ (1) NZ521536A (enExample)
PL (1) PL358666A1 (enExample)
WO (1) WO2001074788A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0024811D0 (en) * 2000-10-10 2000-11-22 Smithkline Beecham Plc Novel compounds
US7176310B1 (en) 2002-04-09 2007-02-13 Ucb Sa Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agents
GB0209262D0 (en) * 2002-04-23 2002-06-05 Biochemie Gmbh Organic compounds
DE60317208T2 (de) * 2002-07-24 2008-08-07 Nabriva Therapeutics Forschungs Gmbh Pleuromutilinderivate als antimikrobielle mittel
GB0218578D0 (en) 2002-08-09 2002-09-18 Glaxo Group Ltd Novel method
GB0308114D0 (en) * 2003-04-08 2003-05-14 Glaxo Group Ltd Novel compounds
FR2856685B1 (fr) * 2003-06-25 2005-09-23 Merck Sante Sas Derives de thiazolylpiperidine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
JP2008523016A (ja) * 2004-12-13 2008-07-03 グラクソ グループ リミテッド (5−アミノ−6−メトキシ−3−ピリジンカルボニル)カルバミン酸2−(s)−ヒドロキシムチリン14−エステルの新規の多形
JPWO2006070671A1 (ja) * 2004-12-27 2008-06-12 杏林製薬株式会社 12位置換ムチリン誘導体
WO2006099196A1 (en) * 2005-03-10 2006-09-21 Smithkline Beecham Corporation Novel method
TW200738701A (en) 2005-07-26 2007-10-16 Du Pont Fungicidal carboxamides
KR100695541B1 (ko) * 2005-10-31 2007-03-16 한국단자공업 주식회사 연결터미널
WO2007079173A2 (en) * 2005-12-30 2007-07-12 Emergent Biosolutions Inc. Novel 2-heteroaryloxy-phenol derivatives as antibacterial agents
JP5322927B2 (ja) 2007-05-24 2013-10-23 杏林製薬株式会社 14位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体
EP2014640A1 (en) * 2007-07-13 2009-01-14 Nabriva Therapeutics AG Pleuromutilin derivatives
JP2010100582A (ja) * 2008-10-24 2010-05-06 Kyorin Pharmaceut Co Ltd 14位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体
EP2184273A1 (de) 2008-11-05 2010-05-12 Bayer CropScience AG Halogen-substituierte Verbindungen als Pestizide
EP2253617A1 (de) 2009-05-20 2010-11-24 Bayer CropScience AG Halogen-substituierte Verbindungen als Pestizide
PT3310331T (pt) * 2015-06-17 2021-01-19 Nabriva Therapeutics GmbH Formulações farmacêuticas injetáveis de lefamulina
JP7631212B2 (ja) 2019-02-27 2025-02-18 オティカラ,インコーポレーテッド 鼻、副鼻腔、および鼻咽頭組織の感染および/または炎症を治療するための方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020368A (en) * 1996-01-03 2000-02-01 Hinks; Jeremy David Carbamoyloxy derivatives of mutiline and their use as antibacterials
HUP0001741A3 (en) 1996-08-02 2000-11-28 Smithkline Beecham Plc Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use, process for preparing them, pharmaceuticals contg. them and their use
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
FR2771008B1 (fr) 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
GB9817029D0 (en) * 1998-08-05 1998-09-30 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
ATE437860T1 (de) 2009-08-15
NO20024745D0 (no) 2002-10-02
HUP0300370A3 (en) 2005-07-28
CA2405132A1 (en) 2001-10-11
US20030114674A1 (en) 2003-06-19
US6972297B2 (en) 2005-12-06
CZ20023290A3 (cs) 2003-03-12
NO20024745L (no) 2002-11-19
AU6382701A (en) 2001-10-15
CN1427827A (zh) 2003-07-02
EP1268443B1 (en) 2009-07-29
DE60139382D1 (de) 2009-09-10
AU2001263827B2 (en) 2004-06-17
EP1268443A1 (en) 2003-01-02
IL151887A0 (en) 2003-04-10
NO324229B1 (no) 2007-09-10
KR100758441B1 (ko) 2007-09-14
JP2003529593A (ja) 2003-10-07
CN1210267C (zh) 2005-07-13
WO2001074788A8 (en) 2001-12-20
HUP0300370A2 (hu) 2003-06-28
BR0109809A (pt) 2003-01-21
KR20030011815A (ko) 2003-02-11
AR030203A1 (es) 2003-08-13
WO2001074788A1 (en) 2001-10-11
NZ521536A (en) 2004-05-28
PL358666A1 (en) 2004-08-09
ES2328109T3 (es) 2009-11-10
MXPA02009816A (es) 2003-03-27

Similar Documents

Publication Publication Date Title
ATE239694T1 (de) Phenylethanolamin-verbindungen und ihre anwendung als beta3 agonisten, verfahren zu ihrer herstellung und zwischenprodukte ihrer herstellung
CO5180568A1 (es) Compuestos farmaceuticos, especialmente mutilinas, composiciones farmaceuticas que los contienen
YU27304A (sh) Novi dihidropteridinoni, postupak za njihovo dobijanje i njihova primena kao lekova
AR054097A1 (es) Sintesis de ester terc-butilico de acido (5-bromo-4-metilpiridin-3-ilmetil)-etilcarbamico
AR025352A1 (es) Compuesto inhibidor de la proteasa del hiv, su uso para preparar medicamentos, composiciones que lo comprenden, procedimientos e intermediarios paraprepararlos y procedimiento para preparar los intermediarios
CO4950563A1 (es) Nuevos compuestos
WO2007039527A3 (en) Thiol dyes
TW200738667A (en) Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof
DK1215201T3 (da) Fremgangsmåde til fremstilling af aryloctanylamider
CO5261496A1 (es) Derivados de heterociclo-alquilsulfonil-pirazol como agentes antiinflamatorios/analgesicos
AR030203A1 (es) Derivados de carbamato de 2-(s)-hidroximutilina, composiciones farmaceuticas que los comprenden, procedimiento para prepararlos y 2(s), 11-dihidroxi protegida-mutilina como compuesto intermediario
BR9808854A (pt) Processo para preparação de um composto, e, composto
AR041786A1 (es) Derivados de azetidina como antagonistas del receptor ccr-3, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la elaboracion de un medicamento
PT1197483E (pt) Processo de reducao catalitica de compostos alcino
MXPA05006073A (es) Proceso para producir (met)acrilatos de carbamoiloxi y nuevos (met)acrilatos de carbamoiloxi.
AU3284699A (en) Process for the preparation of simvastatin and derivatives thereof
BR9912870A (pt) Processo para sìntese de derivados de (1h) - benzo (c)quinolizina-3-onas
CO5540310A2 (es) Derivados de tri- y tetraazaacenaftileno como antagonista del receptor de crf
DE69820481D1 (de) Verfahren zur herstellung von cholecalciferol-derivaten und zwischenverbindungen
DE60222244D1 (de) Verfahren zur herstellung von zwischenverbindungen in der herstellung von discodermolid und discodermolid-analoga
ES2195815T3 (es) Procedimiento para purificar isocianatos organicos.
KR870007902A (ko) 복소환식 화합물
DE59610629D1 (de) Immunogenes konstrukt, verfahren zu dessen herstellung und verwendung als vakzine
WO2004024681A3 (fr) NOUVEAUX COMPOSES COMPRENANT UN GROUPEMENT THIOCARBONYLSULFANYLE UTILES POUR LA SYNTHESE DE COMPOSES α-PERFLUOROALKYLAMINES PAR VOIE RADICALAIRE
BR9400817A (pt) Processo para preparar derivados de sulfoniluréia, processo para preparar derivados de sulfonilcloreto, composto hidróxido de 1-(((pirazolesulfonil)amino)carbonil) piridínio e processo para preparar compostos

Legal Events

Date Code Title Description
FC Application refused